International Conference on Biomaterials for Bone Tissue Engineering November 18-19, 2019 Abu Dhabi, UAE

He was graduated in 1976 as medical doctor at University of La Habana Cuba. Ex fellowship WHO at University of Toronto Canada. With more than 30 year working as specialist in Orthopaedic Surgery is associate professor and associate researcher. Expertise in total joint replacement and external fixators. Paper published 38 in reputable journals, authors of a chapters in two different international books. Nine research submitted and applied. Certificate as invention’s authors CIPO (patented). Since 2015 working at Walter Sisulu University (Nelson Mandela academic Hospital) Eastern cape, South Africa. Currently involved in three research projects.

Total Joint replacement (hip and knee), Bone cementation. , Bone graft substitutes, Bone tumours, Hips and knee disorders in children

Dr.Eugene Zadorin has completed his PhD at the age of 28 years from Cardiology University. He is the director of NBScience, a premier contract research organization. He has published more than 40 papers in reputed journals and has been serving as an editorial board member of repute.

Stem cells therapy is a relatively new and promising direction in the treatment of many serious diseases in which conventional methods fail to achieve the desired results. In the therapeutic aspect of the pathology of the gastrointestinal tract and liver, the most promising at this stage are inflammatory bowel diseases, colorectal cancer and decompensated cirrhosis of the liver. At the same time, clinical application of the embryonic stem cells involves a number of ethical and religious limitations. In contrast to embryonic stem cells, autologous stem cells of the patient is ethical and promising, as it opens up unlimited possibilities of repair, regeneration of tissues, amplification and modeling of the immune system, rejuvenation of all tissues and organs.

Andrew Hague’s interest in the technology that was to become CellSonic began in 1987 with the first lithotripter in Britain. Using his own capital, he developed the CellSonic VIPP machines and sold them around the world. In 2016, Professor Hague devised the protocol for curing cancer and this is now used in CellSonic Clinics in India, Peru, Switzerland and Poland. Many more are planned. There are no side effects, drugs must not be used and the cancer is stopped within three days. CellSonic VIPP has been used for physiotherapy and sports medicine for twenty years. Where the patient also had cut skin the cure for non-healing wounds was discovered and that led to repairing nerves and pain release. Professor Hague is the owner of CellSonic Limited and advises the Universities of Bradford in England and Hyderabad in India.

Tissue regeneration, Cancer - diagnosis and treatment, Diabetes – reversal, Alzheimer’s disease, Parkinson’s disease.

Mr. Deven Patel, the CEO, President and Cofounder of Global Institute of Stem Cell Therapy and Research (GIOSTAR) with headquarter in San Diego, California, U.S.A. GIOSTAR was formed with the vision to provide affordable stem cell based therapies to the masses around the world suffering from degenerative or genetic diseases and unable to afford today’s high cost of the treatment. He was honored with USA Congressional Recognition for his efforts in spreading the advancement of stem cell science around the world. He was also bestowed upon Asian Heritage Award for his business leadership in the field of stem cell science. GIOSTAR under the leadership of Mr. Patel is in charge of developing stem cell transplant program for four different State Governments in India with total population of approx. 155 million. GIOSTAR, in collaborations with Government of Gujarat, India, world's largest state of the art Stem Cell Treatment Hospital in India. GIOSTAR is in process of developing its facility in China, Thailand, Colombia, Bahamas, Dubai and Austalia.

autologous, allogeneic, critical mass, emerging markets